exam 3 lecture 7 Flashcards

1
Q

biologics

A

meds derived from living organisms
recombinant proteins, peptides, blood factors, vaccines, oliognulceotides, cell-based therapy
biotech drugs or biopharmaceuticals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

importance of biologics

A

top 200 drug sales 2018 –> 73 were biologics
top 100 drug sales in 2003 –> 5 were biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

monoclonal antibodies (mAb)

A

two light chains (L)
two heavy chains (H)
linked by SS bonds
antigen binding occurs through variable domain(V) at (CDR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

antibody drug conjugates

A

trojan horse
linker on ADC attaches to cytotoxic agent
combine target specificity of mAb with efficacy of small molecule drugs
can use mAb fragments rather than whole mAb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cytokines

A

IL, INF
neulasta, epogen, avonex, rebif, humatrope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

insulins

A

a-chain and b-chain linked by ss bonds
alpha helical structure –> readily associates to form dimers, hexamers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

insulin analogs

A

lispro insulin: fast acting insulin analog, lys and pro on c-terminus are reversed
aspar insulin: fast acting insulin analog, pro on c-terminus of b-chain mutated to asp
glargin insulin: long acting, asn on a21 mutated to gly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

peptides

A

short proteins less than 50 AAs
some secondary structure, no higher order structure
some chemical modifications
peptide vs peptide analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

peptidomimetic (telaprevir)

A

peptide like structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vaccines

A

types: inactivated, attenuated, toxoid, conjugate, subunit
differ widely in size and structure
can be much larger than other biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cell therapies –> new biologics

A

car-t cell therapies
- remove immune cells from patient’s blood,
- genetically program to fight cancer cells,
- multiplied + infused into patient,
- newly programmed car-t cells kill cancer cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

oligonucleotides –> new biologics

A

used to treat spinal musclar atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

dosage forms for biologics

A

dosing is usually parenteral: except oral vaccines
peptides and proteins cannot be given orally
common dosage forms:
- solution for injection, pen/autoinjector, pre-filled syringe, lyphilized powder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

solution formulation

A

simple and least expensive
convienent for patients and hospital bc they don’t need reconstitution
can be inspected prior to administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical concerns for solutions

A

efficacy, sterility, side effects (dose-limiting immune response)
pain from injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

formulation concerns solutions

A

all clinical concerns
stability: aggregation, chem stability, shelf-life, storage conditions
manufacturing: cost, manufacturing time

17
Q

formulation variables solutions

A

solution properties: ph, ionic strength, drug conc., volume, excipients.
container: materials
Storage conditions: refrigerator vs room, frozen

18
Q

formulation variables: pH

A

rate of sCT degradation depends on pH
pH of maximum stability is 3-4 –> not a pH for injection
additive makes stability worse

19
Q

formulation variables: concentration

A

beta lactoglobulin is a milk protein
higher concentration of it results in increased and greater aggregation
SC delivery required small volumes –> mAb concentrations risk aggregation

20
Q

formulation variables: excipients

A

stabilize proteins
promote interactions with water and stabilize native protein structure
excipients that bind to proteins can lead to denaturation
exception: protein binding to ligands can stabilize native structure

21
Q

Eythropoetin

A

erythropoetin (EPO, Epoetin) is used to treat anemia in renal disease

22
Q

anti-EPO antibodies

A

reduces drug effect and that of any naturally occur EPO

23
Q

Pure red cell aplasia (PRCA)

A

results in sudden onset anemia, death
increasesd PRCA has been associated with change in container closure (stopper)

24
Q

what if solution formulation does not work

A

store at fridge temperature
freeze
freeze-dry or spray-dry to create dried powder for reconstitution
re-engineer protein molecule
abandon drug candidate

25
practical considerations
store at reccommended temp protect from light avoid agitation examine vial for particulates prior to admin be aware of adverse immune response
26
prefilled syringes, autoinjectors, pens
prefilled syringes, pens, autoinjectors are not formulations pen is a medical device solution inside pen is formulation together "combination product"
27
advantages prefilled, pens, auto
ease of use ease of transport discrete increased pt compliance reduced risk of dosage error and product contamination
28
disadvantages prefilled, pens, autos
higher cost than vials + syringes cannot mix two drugs drug waste bc of priming greater surface-volume ratio, presence of lub, induce aggregation of protein drugs
29
prefilled syringe components
syringe barrel leur lock finger grip plunger gasket top cap
30
insulin pen components
cap outer needle inner needle needle protective seal rubber seal insulin reservoir dose window dosage knob injection button
31
common features pen, prefilled, autos
solution dosage forms within a device for admin common features: drug solution, needle, piston/plunger, housing
32
special concerns prefilled, pens, autos
when compared to vials: higher surface-to-volume ratio lower total volume syringe lubes + oils
33
aggregation in syringe
proteins are surfactants that can unfold when exposed to surfaces or interfaces on wall of syringe there is lubricant, which can cause proteins to unfold and dimerize then aggregate
34
advantages lyphilized powders
reduced rates of chem + physical degradation improved drug stability + longer shelf-life refrigerated storage not usually needed can use lyophilized formulations in prefilled, pens, autos
35
disadvantages lyophilized powders
must be reconstituted prior inj less convenient than solutions more expensive and time consuming
36
lyophilized powders
freeze drying removes water by sublimation occurs @ low temp + low pressure gentler than other methods of moving water same for foods
37
lyophilization can cause instability
freeze-concentration can promote aggregation disulfide bond scrambling can be accelerated by freezing and drying protein structure can be perturbed by lyophilization - excipients to inhibit this: lyoprotectants + cryoprotectants aggregated and/or degraded protein can be observed on reconstitution
38
clinical considerations
biologics are usually marketed in lyophilized form because they are unstable in solution use caution: reconsitution, storing + handling, when administering ; visually inspect for particulates